MAPT and Alzheimer disease: Their use allows for the identification of 3R/4R tau deposits in AD with high affinity, staging/stratifying AD, and differentiating it from other tauopathies both by the spatial distribution of tracer deposition and by lower affinity and intensity of uptake in 4R tauopathies105,112,113.